143 related articles for article (PubMed ID: 1386296)
1. Cyclophosphamide treatment antagonizes the in vitro development of Mycobacterium lepraemurium-induced suppressor cell precursors.
Gosselin D; Turcotte R; Lemieux S
Clin Exp Immunol; 1992 Aug; 89(2):185-91. PubMed ID: 1386296
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic characterization of two cell populations involved in the acquisition of suppressor activity by cultured spleen cells from Mycobacterium lepraemurium-infected mice.
Gosselin D; Turcotte R; Lemieux S
Clin Exp Immunol; 1995 Dec; 102(3):515-22. PubMed ID: 8536366
[TBL] [Abstract][Full Text] [Related]
3. Influence of the Ity/Lsh/Bcg gene on the development of suppressor cell precursors in the early phase of the infection of mice with Mycobacterium lepraemurium.
Gosselin D; Turcotte R; Lemieux S
Clin Exp Immunol; 1994 May; 96(2):218-24. PubMed ID: 8187330
[TBL] [Abstract][Full Text] [Related]
4. Early accumulation of suppressor cell precursors in the spleen of Mycobacterium lepraemurium-infected mice and analysis of their in vitro-induced maturation.
Lemieux S; Gosselin D; Lusignan Y; Turcotte R
Clin Exp Immunol; 1990 Jul; 81(1):116-22. PubMed ID: 2143124
[TBL] [Abstract][Full Text] [Related]
5. Evidence for generation of suppressor T cells in Mycobacterium lepraemurium-infected CBA/J mice, a mouse strain highly susceptible to the infection.
Saito N; Hirooka Y
Microbiol Immunol; 1983; 27(1):75-85. PubMed ID: 6223201
[TBL] [Abstract][Full Text] [Related]
6. Cellular target of in vitro-induced suppressor cells derived from the spleen of Mycobacterium lepraemurium-infected mice and role of IFN-gamma in their development.
Gosselin D; Turcotte R; Lemieux S
J Leukoc Biol; 1995 Jan; 57(1):122-8. PubMed ID: 7829963
[TBL] [Abstract][Full Text] [Related]
7. Surface Lyt phenotype of suppressor cells in C57BL/6 mice infected with Mycobacterium lepraemurium.
Hoffenbach A; Lagrange PH; Bach MA
Clin Exp Immunol; 1983 Oct; 54(1):151-7. PubMed ID: 6225581
[TBL] [Abstract][Full Text] [Related]
8. Suppressor T cells for delayed-type hypersensitivity in susceptible mice infected with Mycobacterium lepraemurium.
Richard L; Turcotte R; Forget A
Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):63-9. PubMed ID: 2951464
[TBL] [Abstract][Full Text] [Related]
9. Adoptive transfer of immunity and suppression by cells and serum in early Mycobacterium lepraemurium infections of mice.
Alexander J
Parasite Immunol; 1979; 1(2):159-66. PubMed ID: 399335
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of suppressor cells in the bone marrow and spleens of high dose cyclophosphamide-treated C57Bl/6 mice.
Nikcevich DA; Duffie GP; Young MR; Ellis NK; Kaufman GE; Wepsic HT
Cell Immunol; 1987 Oct; 109(2):349-59. PubMed ID: 2959374
[TBL] [Abstract][Full Text] [Related]
11. Biological properties of factors secreted by antigen-reactive suppressor cells in mice infected with Mycobacterium lepraemurium.
Richard L; Forget A; Turcotte R
Infect Immun; 1990 Nov; 58(11):3531-6. PubMed ID: 1977704
[TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide-induced suppressor cells in mice: suppression of the antibody response in vitro and characterization of the effector cells.
Segre M; Tomei E; Segre D
Cell Immunol; 1985 Apr; 91(2):443-54. PubMed ID: 3158396
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of splenic natural suppressor cells induced in mice by treatment with cyclophosphamide.
Brooks-Kaiser JC; Bourque LA; Hoskin DW
Immunopharmacology; 1993; 25(2):117-29. PubMed ID: 8500984
[TBL] [Abstract][Full Text] [Related]
14. T-suppressor cells sensitive to cyclophosphamide and to its in vitro active derivative 4-hydroperoxycyclophosphamide control the mitogenic response of murine splenic B cells to dextran sulfate. A direct proof for different sensitivities of lymphocyte subsets to cyclophosphamide.
Diamantstein T; Willinger E; Reiman J
J Exp Med; 1979 Dec; 150(6):1571-6. PubMed ID: 159940
[TBL] [Abstract][Full Text] [Related]
15. Genetic resistance of mice to persistent infection with Mycobacterium lepraemurium in vitro: association with macrophage bactericidal responsiveness to lymphokines and dissociation from production of hydrogen peroxide by macrophages.
Sankaran K; Hoffeld JT; Chaparas SD; Oppenheim JJ
J Immunopharmacol; 1984; 6(4):277-89. PubMed ID: 6396334
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of resistance in Mycobacterium lepraemurium infected C3H mice by treatment with sonicated M. lepraemurium or splenectomy.
Turcotte R; Chaput J; Lemieux S
Clin Exp Immunol; 1984 Apr; 56(1):97-104. PubMed ID: 6370521
[TBL] [Abstract][Full Text] [Related]
17. Influence of route of Mycobacterium lepraemurium injection on susceptibility to mouse leprosy and on lymphoblastic transformation.
Turcotte R
Infect Immun; 1980 Jun; 28(3):660-8. PubMed ID: 6995320
[TBL] [Abstract][Full Text] [Related]
18. The evolution of immunosuppressive cell populations in experimental mycobacterial infection.
Bullock WE; Carlson EM; Gershon RK
J Immunol; 1978 May; 120(5):1709-16. PubMed ID: 351057
[TBL] [Abstract][Full Text] [Related]
19. Influence of dose and route of Mycobacterium lepraemurium inoculation on the production of interleukin 1 and interleukin 2 in C57BL/6 mice.
Hoffenbach A; Lagrange PH; Bach MA
Infect Immun; 1984 Jun; 44(3):665-71. PubMed ID: 6373613
[TBL] [Abstract][Full Text] [Related]
20. Influence of dose and route of inoculation and of mouse strain on the production of interleukin 2 in mice infected with Mycobacterium lepraemurium.
Hoffenbach A; Lagrange PH; Bach MA
Acta Leprol; 1984; 2(2-4):413-20. PubMed ID: 6398600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
